宋克东

  研究员   博士生导师   硕士生导师


当前位置: 中文主页 >> 科学研究 >> 论文成果

Detection and Evaluation of Anti-Cancer Efficiency of Astragalus Polysaccharide Via a Tissue Engineered Tumor Model

论文类型:期刊论文

发表时间:2018-11-01

发表刊物:MACROMOLECULAR BIOSCIENCE

收录刊物:PubMed、SCIE

卷号:18

期号:11

页面范围:e1800223

ISSN号:1616-5187

关键字:3D tumor models; astragalus polysaccharides; decellularized porcine lung scaffolds; immunoregulation; macrophage activation

摘要:Polysaccharides have been known to display their anti-cancer activity via immunomodulation. The immunomodulation of RAW 246.7 macrophages by astragalus polysaccharide (APS) is herein studied in human breast cancer cells. Apart from traditional 2D culture, a novel tissue-engineered tumor model is prepared based on decellularized porcine lung scaffold. Decellularized lung scaffolds exhibit preferable biocompatibility that promote the formation and enlargement of tumor spheroids. The conditioned medium (CM, the supernatant liquid of APS-treated RAW264.7 macrophages) shows anti-cancer activity by inhibiting cell proliferation, demonstrated by a 39.25 +/- 5.04% decrease in tumoroid size and 20.96 +/- 2.43% reduction in cell viability, and promoting cell apoptosis by the nuclear fragmentation and increasing apoptotic-stage proportion. The cytotoxicity of CM is associated with the upregulated production of nitric oxide and tumor necrosis factor-alpha from RAW 246.7 cells stimulated by APS. Overall, by using this 3D tumor model to study CM, there is convincing evidence that APS can modulate macrophage function to further mediate anti-cancer activity.

上一条: Thermally Assisted Electrohydrodynamic Jet High-Resolution Printing of High-Molecular Weight Biopolymer 3D Structures

下一条: Design and Biophysical Characterization of Poly (L-Lactic) Acid Microcarriers with and without Modification of Chitosan and Nanohydroxyapatite